Cover Image
市場調查報告書

免疫調節藥物市場分析:各產品(免疫抑制劑,免疫刺激劑,疫苗,抗體),各用途(腫瘤,呼吸系統,HIV),各地區,及市場區隔預測

Immunomodulators Market Analysis By Product (Immunosuppressant, Immunostimulants, Vaccines, Antibodies), By Application (Oncology, Respiratory, HIV), By Region, And Segment Forecasts, 2014 - 2025

出版商 Grand View Research, Inc. 商品編碼 421177
出版日期 內容資訊 英文 101 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
免疫調節藥物市場分析:各產品(免疫抑制劑,免疫刺激劑,疫苗,抗體),各用途(腫瘤,呼吸系統,HIV),各地區,及市場區隔預測 Immunomodulators Market Analysis By Product (Immunosuppressant, Immunostimulants, Vaccines, Antibodies), By Application (Oncology, Respiratory, HIV), By Region, And Segment Forecasts, 2014 - 2025
出版日期: 2016年12月07日 內容資訊: 英文 101 Pages
簡介

本報告提供全球免疫調節藥物市場相關調查,彙整市場趨勢,各產品,各用途,各地區趨勢,及打入市場的主要企業簡介等資料。

第1章 調查方法與範圍

第2章 摘要整理

第3章 市場變動,趨勢,範圍

  • 市場區隔和範圍
    • 促進要素分析
    • 阻礙要素分析
  • 滲透與成長製圖
  • 大環境分析
  • 產業分析:波特五力分析

第4章 各產品預測·趨勢分析

  • 各產品趨勢分析
  • 免疫抑制劑
  • 免疫刺激劑

第5章 各用途市場預測·趨勢分析

  • 各用途趨勢分析·市場佔有率
  • 腫瘤
  • 呼吸系統
  • HIV
  • 其他

第6章 各地區預測·趨勢分析

  • 各地區市場佔有率
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第7章 競爭環境

  • 策略架構
  • 市場進入分類
  • 企業簡介
目錄
Product Code: GVR-1-68038-318-8

The global immunomodulators market is expected to reach USD 233.7 billion by 2025, according to a new study by Grand View Research, Inc. The market is anticipated to be predominantly driven by high R&D investments employed by the prominent companies, resulting into the large-scale production of new and therapeutically advanced drugs. This is believed to widen the influx of drugs at an unprecedented rate into the immunomodulators market hence providing highly efficacious treatment alternatives for numerous autoimmune and inflammatory diseases.

In addition, increasing drugs resistance is predicted to be responsible for boosting the clinical urgency to develop potentially new generation immunomodulators with targeted therapy mechanisms. The aforementioned factors cumulatively are expected to present significant growth opportunities over the forecast period.

Furthermore, burgeoning presence of the key players is expected to promote the awareness levels pertaining to benefits of immunomodulators amongst the patients as well as the physicians. This is further expected to widen the immunomodulators industry growth potential during the forecast period.

In addition, increasing adoption of monoclonal antibodies for a wide range of indications, such as, multiple sclerosis, Crohn's disease, rheumatoid arthritis, and Non-Hodgkin's Lymphoma, which is expected to boost immunomodulators industry over the forecast period. The consistent number of product approvals of highly significant monoclonal antibodies in autoimmune diseases is predicted to be responsible for widening the scope of growth.

Further Key Findings From the Study Suggest:

  • Immunosuppressant held the largest share of the product segment in 2015, owing to increasing number of transplantation procedures and need to prevent organ rejection
  • Antibodies held the dominant share of immunosuppressant in 2015, owing to extensive utilization in kidney, liver, heart, and lung transplants resulting in greater revenue generation
  • Immunostimulants expected to grow lucratively as a result of lower influx of immunostimulant generics for application in HIV, cancer and multiple sclerosis
  • In 2015, North America dominated the global immunomodulators market owing to presence of wide number of established pharmaceutical companies involved in extensive commercialization
  • The prominent participants are undertaking research and clinical collaborative strategies to yield new drugs and thereby to gain competitive advantage
  • For instance, in March 2015, Novartis AG entered into research collaboration with Aduro Biotech. This was carried out to enhance its next generation cancer immunotherapy product pipeline

Table of Content

Chapter 1 Research Methodology & Scope

  • 1.1 Region Wise Market Calculation
    • 1.1.1 Region Wise Market: Base Estimates
    • 1.1.2 Global Market: CAGR Calculation
  • 1.2 Region-based segment share calculation
  • 1.3 List of Secondary Sources

Chapter 2 Executive Summary

  • 2.1 Market Snapshot

Chapter 3 Immunomodulators Market Variables, Trends & Scope

  • 3.1 Market segmentation & scope
    • 3.1.1 Market Driver Analysis
      • 3.1.1.1 Increasing adoption of monoclonal antibodies
      • 3.1.1.2 Rising incidence of cancer and other chronic conditions
      • 3.1.1.3 Presence of strong pipeline portfolio
    • 3.1.2 Market Restraint Analysis
      • 3.1.2.1 High number of patent expiration
      • 3.1.2.2 Growing generic & biosimilars competition
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Immunomodulators - PESTLE Analysis
  • 3.4 Industry Analysis - Porter's

Chapter 4 Immunomodulators Product Estimates & Trend Analysis

  • 4.1 Immunomodulators Market: Product Movement Analysis
  • 4.2 Immunosuppressants
    • 4.2.1 Immunosuppressants market, 2014 - 2025 (USD Billion)
    • 4.2.2 Antibodies
      • 4.2.2.1 Antibodies market, 2014 - 2025 (USD Billion)
    • 4.2.3 Calcineurin inhibitors
      • 4.2.3.1 Calcineurin inhibitors market, 2014 - 2025 (USD Billion)
    • 4.2.4 Glucocorticoid
      • 4.2.4.1 Antimetabolites market, 2014 - 2025 (USD Billion)
    • 4.2.5 Antimetabolites
      • 4.2.5.1 Antimetabolites market, 2014 - 2025 (USD Billion)
    • 4.2.6 Others
      • 4.2.6.1 Others market, 2014 - 2025 (USD Billion)
  • 4.3 Immunostimulants
    • 4.3.1 Immunostimulants market, 2014 - 2025 (USD Billion)
    • 4.3.2 Vaccines
      • 4.3.2.1 Vaccines market, 2014 - 2025 (USD Billion)
    • 4.3.3 Antibodies
      • 4.3.3.1 Antibodies market, 2014 - 2025 (USD Billion)
    • 4.3.4 Others
      • 4.3.4.1 Others market, 2014 - 2025 (USD Billion)

Chapter 5 Immunomodulators Application Estimates & Trend Analysis

  • 5.1 Immunomodulators Market: Application Movement Analysis
  • 5.2 Oncology
    • 5.2.1 Oncology s market, 2014 - 2025 (USD Billion)
  • 5.3 Respiratory
    • 5.3.1 Respiratory market, 2014 - 2025 (USD Billion)
  • 5.4 HIV
    • 5.4.1 HIV market, 2014 - 2025 (USD Billion)
  • 5.5 Others
    • 5.5.1 Others market, 2014 - 2025 (USD Billion)

Chapter 6 Immunomodulators Regional Estimates & Trend Analysis, by Product and Applications

  • 6.1 Immunomodulators market share by region, 2015 & 2024
  • 6.2 North America
    • 6.2.1 North America immunomodulators market, 2014 - 2025 (USD Billion)
    • 6.2.2 U.S.
      • 6.2.2.1 U.S. immunomodulators market, 2014 - 2025 (USD Billion)
    • 6.2.3 Canada
      • 6.2.3.1 Canada Immunomodulators market, 2014 - 2025 (USD Billion)
  • 6.3 Europe
    • 6.3.1 Europe Immunomodulators market, 2014 - 2025 (USD Billion)
    • 6.3.2 UK
      • 6.3.2.1 UK Immunomodulators market, 2014 - 2025 (USD Billion)
    • 6.3.3 Germany
      • 6.3.3.1 Germany Immunomodulators market, 2014 - 2025 (USD Billion)
  • 6.4 Asia Pacific
    • 6.4.1 Asia Pacific Immunomodulators market, 2014 - 2025 (USD Billion)
    • 6.4.2 Japan
      • 6.4.2.1 Japan Immunomodulators market, 2014 - 2025 (USD Billion)
    • 6.4.3 China
      • 6.4.3.1 China Immunomodulators market, 2014 - 2025 (USD Billion)
    • 6.4.4 India
      • 6.4.4.1 India Immunomodulators market, 2014 - 2025 (USD Billion)
  • 6.5 Latin America
    • 6.5.1 Latin America Immunomodulators market, 2014 - 2025 (USD Billion)
    • 6.5.2 Brazil
      • 6.5.2.1 Brazil Immunomodulators market, 2014 - 2025 (USD Billion)
    • 6.5.3 Mexico
      • 6.5.3.1 Mexico Immunomodulators market, 2014 - 2025 (USD Billion)
  • 6.6 MEA
    • 6.6.1 MEA Immunomodulators market, 2014 - 2025 (USD Billion)
    • 6.6.2 South Africa
      • 6.6.2.1 South Africa Immunomodulators market, 2014 - 2025 (USD Billion)

Chapter 7 Competitive Landscape

  • 7.1 Strategy framework
  • 7.2 Market participation categorization
  • 7.3 Company Profiles
    • 7.3.1 F. Hoffmann-La Roche Ltd.
      • 7.3.1.1 Company Overview
      • 7.3.1.2 Financial Performance
      • 7.3.1.3 Product Benchmarking
      • 7.3.1.4 Strategic Initiatives
    • 7.3.2 Amgen, Inc.
      • 7.3.2.1 Company Overview
      • 7.3.2.2 Financial Performance
      • 7.3.2.3 Product Benchmarking
      • 7.3.2.4 Strategic Initiatives
    • 7.3.3 Abbott
      • 7.3.3.1 Company Overview
      • 7.3.3.2 Financial Performance
      • 7.3.3.3 ProductBenchmarking
      • 7.3.3.4 Strategic Initiatives
    • 7.3.4 Johnson & Johnson
      • 7.3.4.1 Company Overview
      • 7.3.4.2 Financial Performance
      • 7.3.4.3 Product Benchmarking
      • 7.3.4.4 Strategic Initiatives
    • 7.3.5 Novartis AG
      • 7.3.5.1 Company Overview
      • 7.3.5.2 Financial Performance
      • 7.3.5.3 Product Benchmarking
      • 7.3.5.4 Strategic Initiatives
    • 7.3.6 Eli Lilly and Company
      • 7.3.6.1 Company Overview
      • 7.3.6.2 Financial Performance
      • 7.3.6.3 Product Benchmarking
    • 7.3.7 Bristol-Myers Squibb Company
      • 7.3.7.1 Company Overview
      • 7.3.7.2 Financial Performance
      • 7.3.7.3 Product Benchmarking
      • 7.3.7.4 Strategic Initiatives
    • 7.3.8 Merck & Co., Inc.
      • 7.3.8.1 Company Overview
      • 7.3.8.2 Financial Performance
      • 7.3.8.3 Product Benchmarking
      • 7.3.8.4 Strategic Initiatives
    • 7.3.9 Biogen
      • 7.3.9.1 Company Overview
      • 7.3.9.2 Financial Performance
      • 7.3.9.3 Product Benchmarking
      • 7.3.9.4 Strategic Initiatives

List of Tables

  • TABLE 1 North America immunomodulators market, by product, 2014 - 2025 (USD Billion)
  • TABLE 2 North America immunosuppressants market, by type, 2014 - 2025 (USD Billion)
  • TABLE 3 North America immunostimulants market, by type, 2014 - 2025 (USD Billion)
  • TABLE 4 North America immunomodulators market, by applications, 2014 - 2025 (USD Billion)
  • TABLE 5 U.S. immunomodulators market, by product, 2014 - 2025 (USD Billion)
  • TABLE 6 U.S. immunosuppressants market, by type, 2014 - 2025 (USD Billion)
  • TABLE 7 U.S. immunostimulants market, by type, 2014 - 2025 (USD Billion)
  • TABLE 8 U.S. immunomodulators market, by applications, 2014 - 2025 (USD Billion)
  • TABLE 9 Canada immunomodulators market, by product, 2014 - 2025 (USD Billion)
  • TABLE 10 Canada immunosuppressants market, by type, 2014 - 2025 (USD Billion)
  • TABLE 11 Canada immunostimulants market, by type, 2014 - 2025 (USD Billion)
  • TABLE 12 Canada immunomodulators market, by applications, 2014 - 2025 (USD Billion)
  • TABLE 13 Europe immunomodulators market, by product, 2014 - 2025 (USD Billion)
  • TABLE 14 Europe immunosuppressants market, by type, 2014 - 2025 (USD Billion)
  • TABLE 15 Europe immunostimulants market, by type, 2014 - 2025 (USD Billion)
  • TABLE 16 Europe immunomodulators market, by applications, 2014 - 2025 (USD Billion)
  • TABLE 17 UK immunomodulators market, by product, 2014 - 2025 (USD Billion)
  • TABLE 18 UK immunosuppressants market, by type, 2014 - 2025 (USD Billion)
  • TABLE 19 UK immunostimulants market, by type, 2014 - 2025 (USD Billion)
  • TABLE 20 UK immunomodulators market, by applications, 2014 - 2025 (USD Billion)
  • TABLE 21 Germany immunomodulators market, by product, 2014 - 2025 (USD Billion)
  • TABLE 22 Germany immunosuppressants market, by type, 2014 - 2025 (USD Billion)
  • TABLE 23 Germany immunostimulants market, by type, 2014 - 2025 (USD Billion)
  • TABLE 24 Germany immunomodulators market, by applications, 2014 - 2025 (USD Billion)
  • TABLE 25 Asia Pacific immunomodulators market, by product, 2014 - 2025 (USD Billion)
  • TABLE 26 Asia Pacific immunosuppressants market, by type, 2014 - 2025 (USD Billion)
  • TABLE 27 Asia Pacific immunostimulants market, by type, 2014 - 2025 (USD Billion)
  • TABLE 28 Asia Pacific immunomodulators market, by applications, 2014 - 2025 (USD Billion)
  • TABLE 29 Japan immunomodulators market, by product, 2014 - 2025 (USD Billion)
  • TABLE 30 Japan immunosuppressants market, by type, 2014 - 2025 (USD Billion)
  • TABLE 31 Japan immunostimulants market, by type, 2014 - 2025 (USD Billion)
  • TABLE 32 Japan immunomodulators market, by applications, 2014 - 2025 (USD Billion)
  • TABLE 33 China immunomodulators market, by product, 2014 - 2025 (USD Billion)
  • TABLE 34 China immunosuppressants market, by type, 2014 - 2025 (USD Billion)
  • TABLE 35 China immunostimulants market, by type, 2014 - 2025 (USD Billion)
  • TABLE 36 China immunomodulators market, by applications, 2014 - 2025 (USD Billion)
  • TABLE 37 India immunomodulators market, by product, 2014 - 2025 (USD Billion)
  • TABLE 38 India immunosuppressants market, by type, 2014 - 2025 (USD Billion)
  • TABLE 39 India immunostimulants market, by type, 2014 - 2025 (USD Billion)
  • TABLE 40 India immunomodulators market, by applications, 2014 - 2025 (USD Billion)
  • TABLE 41 Latin America immunomodulators market, by product, 2014 - 2025 (USD Billion)
  • TABLE 42 Latin America immunosuppressants market, by type, 2014 - 2025 (USD Billion)
  • TABLE 43 Latin America immunostimulants market, by type, 2014 - 2025 (USD Billion)
  • TABLE 44 Latin America immunomodulators market, by applications, 2014 - 2025 (USD Billion)
  • TABLE 45 Brazil immunomodulators market, by product, 2014 - 2025 (USD Billion)
  • TABLE 46 Brazil immunosuppressants market, by type, 2014 - 2025 (USD Billion)
  • TABLE 47 Brazil immunostimulants market, by type, 2014 - 2025 (USD Billion)
  • TABLE 48 Brazil immunomodulators market, by applications, 2014 - 2025 (USD Billion)
  • TABLE 49 Mexico immunomodulators market, by product, 2014 - 2025 (USD Billion)
  • TABLE 50 Mexico immunosuppressants market, by type, 2014 - 2025 (USD Billion)
  • TABLE 51 Mexico immunostimulants market, by type, 2014 - 2025 (USD Billion)
  • TABLE 52 Mexico immunomodulators market, by applications, 2014 - 2025 (USD Billion)
  • TABLE 53 MEA immunomodulators market, by product, 2014 - 2025 (USD Billion)
  • TABLE 54 MEA immunosuppressants market, by type, 2014 - 2025 (USD Billion)
  • TABLE 55 MEA immunostimulants market, by type, 2014 - 2025 (USD Billion)
  • TABLE 56 MEA immunomodulators market, by applications, 2014 - 2025 (USD Billion)
  • TABLE 57 South Africa immunomodulators market, by product, 2014 - 2025 (USD Billion)
  • TABLE 58 South Africa immunosuppressants market, by type, 2014 - 2025 (USD Billion)
  • TABLE 59 South Africa immunostimulants market, by type, 2014 - 2025 (USD Billion)
  • TABLE 60 South Africa immunomodulators market, by applications, 2014 - 2025 (USD Billion)

List of Figures

  • FIG. 1 Market summary
  • FIG. 2 Market trends & outlook
  • FIG. 3 Market segmentation & scope
  • FIG. 4 Market driver relevance analysis (Current & future impact)
  • FIG. 5 Market restraint relevance analysis (Current & future impact)
  • FIG. 6 Penetration & Growth Prospect Mapping
  • FIG. 7 Immunomodulators PESTLE Analysis
  • FIG. 8 Porter's Five Forces Analysis
  • FIG. 9 Immunomodulators market product outlook key takeaways
  • FIG. 10 Immunomodulators market: Drug class movement analysis
  • FIG. 11 Immunosuppressants market, 2014 - 2025 (USD Billion)
  • FIG. 12 Antibodies market, 2014 - 2025 (USD Billion)
  • FIG. 13 Calcineurin inhibitors market, 2014 - 2025 (USD Billion)
  • FIG. 14 Glucocorticoid market, 2014 - 2025 (USD Billion)
  • FIG. 15 Antimetabolites market, 2014 - 2025 (USD Billion)
  • FIG. 16 Others market, 2014 - 2025 (USD Billion)
  • FIG. 17 Immunostimulants market, 2014 - 2025 (USD Billion)
  • FIG. 18 Vaccines market, 2014 - 2025 (USD Billion)
  • FIG. 19 Antibodies market, 2014 - 2025 (USD Billion)
  • FIG. 20 Others market, 2014 - 2025 (USD Billion)
  • FIG. 21 Immunomodulators market application outlook key takeaways
  • FIG. 22 Immunomodulators market: Indications movement analysis
  • FIG. 23 Oncology market, 2014 - 2025 (USD Billion)
  • FIG. 24 Respiratory market, 2014 - 2025 (USD Billion)
  • FIG. 25 HIV market, 2014 - 2025 (USD Billion)
  • FIG. 26 Others market, 2014 - 2025 (USD Billion)
  • FIG. 27 Regional marketplace: Key takeaways
  • FIG. 28 Regional outlook, 2015 & 2024
  • FIG. 29 North America immunomodulators market, 2014 - 2025 (USD Billion)
  • FIG. 30 U.S. immunomodulators market, 2014 - 2025 (USD Billion)
  • FIG. 31 Canada Immunomodulators market, 2014 - 2025 (USD Billion)
  • FIG. 32 Europe Immunomodulators market, 2014 - 2025 (USD Billion)
  • FIG. 33 UK Immunomodulators market, 2014 - 2025 (USD Billion)
  • FIG. 34 Germany Immunomodulators market, 2014 - 2025 (USD Billion)
  • FIG. 35 Asia Pacific Immunomodulators market, 2014 - 2025 (USD Billion)
  • FIG. 36 Japan Immunomodulators market, 2014 - 2025 (USD Billion)
  • FIG. 37 China Immunomodulators market, 2014 - 2025 (USD Billion)
  • FIG. 38 India Immunomodulators market, 2014 - 2025 (USD Billion)
  • FIG. 39 Latin America Immunomodulators market, 2014 - 2025 (USD Billion)
  • FIG. 40 Brazil Immunomodulators market, 2014 - 2025 (USD Billion)
  • FIG. 41 Mexico Immunomodulators market, 2014 - 2025 (USD Billion)
  • FIG. 42 MEA Immunomodulators market, 2014 - 2025 (USD Billion)
  • FIG. 43 South Africa Immunomodulators market, 2014 - 2025 (USD Billion)
  • FIG. 44 Strategy framework
  • FIG. 45 Participant categorization
Back to Top